Related Experiment Video
Updated: Jun 4, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation
G V Baracho1, A V Miletic, S A Omori
1Program on Inflammatory Disease Research, Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Abstract:
Phosphoinositide 3-kinase (PI3K) defines a family of lipid kinases that direct a wide range of cellular processes and cell fate decisions. Since its discovery, and that of its enzymatic antagonist PTEN, much of the focus on PI3K has been on its oncogenic potential. In recent years, studies on PI3K signaling in B lymphocytes have established the importance of this pathway in effecting B cell differentiation and associated molecular events such as V(D)J recombination and class switch recombination. Intriguing new findings also indicate that there is specificity in the PI3K pathway in B cells, including preferential expression or usage of particular PI3K isoforms and counter-regulation by the PTEN and SHIP phosphatases. The role of PI3K adaptor proteins (CD19, BCAP, and TC21) has also undergone revision to reflect both shared and unique properties. The emergence of Foxo1 as a critical PI3K regulatory target for B cell differentiation has united membrane proximal regulatory events orchestrated by PI3K/PTEN/SHIP with key transcriptional targets. Insights into the regulation and impact of PI3K signaling have been brought to bear in new treatments for B cell malignancies, and will also be an important topic of consideration for B cell-dependent autoimmune diseases.
Insights
Phosphoinositide 3-kinase (PI3K) signaling is crucial for B cell differentiation and function. New research reveals pathway specificity and identifies Foxo1 as a key target, impacting B cell malignancies and autoimmune diseases.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Phosphoinositide 3-kinase (PI3K) is a lipid kinase family regulating cellular processes.
- PI3K and its antagonist PTEN have been primarily studied for their oncogenic roles.
- PI3K signaling is vital for B lymphocyte differentiation and molecular events like V(D)J recombination.
Purpose of the Study:
- To explore the specific roles and regulation of PI3K signaling in B cells.
- To investigate the interplay between PI3K pathway components and their targets.
- To connect PI3K pathway insights to B cell malignancies and autoimmune diseases.
Main Methods:
- Review of recent studies on PI3K signaling in B lymphocytes.
- Analysis of PI3K isoform specificity and phosphatase counter-regulation (PTEN, SHIP).
- Examination of PI3K adaptor proteins (CD19, BCAP, TC21) and the Foxo1 transcription factor.
Main Results:
- PI3K pathway exhibits specificity in B cells, with distinct isoform usage and phosphatase regulation.
- PI3K adaptor proteins have revised roles, showing both shared and unique functions.
- Foxo1 emerges as a key PI3K regulatory target, linking membrane events to transcriptional control.
Conclusions:
- Understanding PI3K pathway regulation in B cells is critical for their differentiation and function.
- Specific PI3K pathway components and targets, like Foxo1, offer therapeutic avenues for B cell malignancies.
- PI3K signaling insights are relevant for managing B cell-dependent autoimmune diseases.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

